FindTrial
Sign In

evaluation of efficacy of herbal lepa and vati in non healing wound(Dushta vrana) and also its role in infection

A clinical and microbiological study to evaluate the efficacy of Putikadi lepa and Vidangadi vatika guggulu in Dushta vrana

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019313
Enrollment
40
Registered
2019-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L984- Non-pressure chronic ulcer of skin, not elsewhere classified Health Condition 2: L979- Non-pressure chronic ulcer of unspecified part of lower leg Health Condition 3: L899- Pressure ulcer of unspecified site

Interventions

Intervention1: Putikadi lepa: putikadi lepa(Sushruta Samhita chikitsasthana 9/40) for local application. Ingredients- Putikaranja (Holoptelia integrifolia ) Arka ( Calotropis procera ) Snuhi ( Euphorb

Sponsors

self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having chronic wounds more than 6 weeks, nutritional ulcer, diabetic ulcer, neurogenic ulcer, arterial ulcer, venous ulcer.

Exclusion criteria

Exclusion criteria: Shudh vrana/simple wounds, tubercular ulcers, syphilitic ulcers, malignant ulcers.

Design outcomes

Primary

MeasureTime frame
The work is yet to be started and primary outcome will be assessed on an interval of one month.Timepoint: The work is due to be finished by June 2020—

Secondary

MeasureTime frame
After completion of trial secondary outcome will be assessed on an interval of 15 days and effect of treatment will be analized.Timepoint: The work is due to be finished by June 2020—

Countries

India

Contacts

Public ContactPriti Yadav

uttrakhand ayurved university Gurkul Campus Haridwar

drdevesh.shukla@gmail.com9412155386

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026